BioSciKin

BioSciKin functions as a biotechnology accelerator and investment vehicle focused on driving drug innovation. The company identifies and supports promising early-stage life science projects, particularly in precision medicine. It facilitates the development of novel therapeutic solutions through incubation, strategic investment, and licensing.

Originating as a specialized entity spun out from the Simcere Pharmaceutical Group, a leading innovative pharmaceutical company, BioSciKin was established to actively engage with external research and development. Its founders recognized the potential for accelerating scientific breakthroughs by fostering ventures, leveraging Simcere's extensive industry expertise.

BioSciKin primarily serves life science startups and research teams, offering resources and strategic access to global markets, including US-China collaborations. The company's vision is to cultivate a dynamic ecosystem for drug discovery, aiming to advance innovative treatments that address significant unmet medical needs and ultimately enhance patient care.